TaiMed Biologics (4147) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 中裕

TaiMed Biologics (4147) reported revenue of NT$52.4 million for Oct 2026, +35.7% year on year and -2.7% from the previous month. Revenue for Jan–Oct 2026 was NT$552.4 million (+10.5% year on year).

In Oct 2026, it ranked No. 98 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$41.8 million24/10Nov 2024 NT$57.2 millionDec 2024 NT$46.7 millionJan 2025 NT$49.8 millionFeb 2025 NT$48.4 million25/02Mar 2025 NT$78 millionApr 2025 NT$38.8 millionMay 2025 NT$44.3 millionJun 2025 NT$54.5 million25/06Jul 2025 NT$37.8 millionAug 2025 NT$50.6 millionSep 2025 NT$59.2 millionOct 2025 NT$38.6 million25/10Nov 2025 NT$37.9 millionDec 2025 NT$73.3 millionJan 2026 NT$37.9 millionFeb 2026 NT$49.8 million26/02Mar 2026 NT$78.4 millionApr 2026 NT$47.2 millionMay 2026 NT$63.3 millionJun 2026 NT$45.3 million26/06Jul 2026 NT$63.7 millionAug 2026 NT$60.5 millionSep 2026 NT$53.9 millionOct 2026 NT$52.4 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$52.4 million+35.7%-2.7%
Sep 2026NT$53.9 million-9.1%-10.9%
Aug 2026NT$60.5 million+19.5%-5.1%
Jul 2026NT$63.7 million+68.4%+40.7%
Jun 2026NT$45.3 million-16.9%-28.6%
May 2026NT$63.3 million+42.9%+34.1%
Apr 2026NT$47.2 million+21.8%-39.8%
Mar 2026NT$78.4 million+0.5%+57.6%
Feb 2026NT$49.8 million+2.9%+31.4%
Jan 2026NT$37.9 million-24.0%-48.3%
Dec 2025NT$73.3 million+56.9%+93.3%
Nov 2025NT$37.9 million-33.7%-1.9%
Oct 2025NT$38.6 million-7.5%-34.8%
Sep 2025NT$59.2 million+35.0%+17.1%
Aug 2025NT$50.6 million+0.6%+33.8%
Jul 2025NT$37.8 million-14.6%-30.5%
Jun 2025NT$54.5 million+23.8%+22.9%
May 2025NT$44.3 million-3.1%+14.3%
Apr 2025NT$38.8 million-32.2%-50.3%
Mar 2025NT$78 million+3.6%+61.3%
Feb 2025NT$48.4 million-19.0%-2.9%
Jan 2025NT$49.8 million+13.6%+6.6%
Dec 2024NT$46.7 million-20.5%-18.3%
Nov 2024NT$57.2 million+1.4%+37.0%
Oct 2024NT$41.8 million-2.7%-4.8%

Jan–Oct 2026 cumulative: NT$552.4 million (+10.5% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: TaiMed Biologics vs PEC / TaiMed Biologics vs Lotus Pharm / TaiMed Biologics vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

每月營收受行銷夥伴每月進貨數量及CDMO生產時程影響而會有波動,但公司仍持續朝整年銷售目標前進

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16